Larvol Delta - Arch-Biopartners-Announces-Dosing-of-First-Patient-in-Phase-II-Trial-for-LSALT-Peptide-Targeting-Cardiac-Surgery-AssociatedAcute-Kidney-Injury

MetaBlok (lsalt peptide) - Arch Biopartners

https://www.globenewswire.com/news-release/2024/03/07/2842126/0/en/Arch-Biopartners-Announces-Dosing-of-First-Patient-in-Phase-II-Trial-for-LSALT-Peptide-Targeting-Cardiac-Surgery-Associated-Acute-Kidney-Injury.html

Mar 7, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next